Abstract: The present invention relates to a reliable method of prediction of lower respiratory tract infection or inflammation in humans, wherein the level of pancreatic stone protein/regenerating protein (PSP/reg) is determined in serum, and a high level is indicative of the development and the severity of the disease, allowing the classification of patients according to risk.
Type:
Grant
Filed:
March 5, 2018
Date of Patent:
August 2, 2022
Assignees:
UNIVERSITY HOSPITAL OF BASEL, Lascco SA
Abstract: The present invention is directed to new compositions uses thereof and related methods for the treatment of a motoneuron disease or disorder. In particular, the invention relates to the new use of IFN? antagonists or viral vectors, uses, compositions thereof and related methods for the treatment of motoneuron disease or disorder such as ALS.
Type:
Application
Filed:
November 18, 2010
Publication date:
November 1, 2012
Applicants:
UNIVERSITE D'AIX-MARSEILLE, LASCCO SA
Inventors:
Samareh Azeredo Da Silveira Lajaunias, Julianne Aebischer, Cedric Raoul